ASTRAZENECA PLC (AZN)
Clinical trial NCT07518459 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-28 → 2026-05-26 3. primary completion date: 2026-05-28 → 2026-05-26 4. enrollment: 8 → 16 participants
Clinical trial NCT07518459 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-28 → 2026-05-26 3. primary completion date: 2026-05-28 → 2026-05-26 4. enrollment: 8 → 16 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical